BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fhu CW, Ali A. Fatty Acid Synthase: An Emerging Target in Cancer. Molecules 2020;25:E3935. [PMID: 32872164 DOI: 10.3390/molecules25173935] [Cited by in Crossref: 67] [Cited by in F6Publishing: 76] [Article Influence: 33.5] [Reference Citation Analysis]
Number Citing Articles
1 Jia W, Di C, Shi L. Applications of lipidomics in goat meat products: Biomarkers, structure, nutrition interface and future perspectives. Journal of Proteomics 2023;270:104753. [DOI: 10.1016/j.jprot.2022.104753] [Reference Citation Analysis]
2 Moreira-barbosa C, Matos A, Fernandes R, Mendes-ferreira M, Rodrigues R, Cruz T, Costa ÂM, Cardoso AP, Ghilardi C, Oliveira MJ, Ribeiro R. The role of fatty acids metabolism on cancer progression and therapeutics development. Bioactive Lipids 2023. [DOI: 10.1016/b978-0-12-824043-4.00007-5] [Reference Citation Analysis]
3 Xu K, Xia P, Liu P, Zhang X. A six lipid metabolism related gene signature for predicting the prognosis of hepatocellular carcinoma. Sci Rep 2022;12:20781. [PMID: 36456877 DOI: 10.1038/s41598-022-25356-2] [Reference Citation Analysis]
4 Nicastro R, Brohée L, Alba J, Nüchel J, Figlia G, Kipschull S, Gollwitzer P, Romero-pozuelo J, Fernandes SA, Lamprakis A, Vanni S, Teleman AA, De Virgilio C, Demetriades C. Malonyl-CoA is an ancient physiological ATP-competitive mTORC1 inhibitor.. [DOI: 10.1101/2022.11.06.515351] [Reference Citation Analysis]
5 Raskov H, Gaggar S, Tajik A, Orhan A, Gögenur I. Metabolic switch in cancer-Survival of the fittest. European Journal of Cancer 2022. [DOI: 10.1016/j.ejca.2022.11.025] [Reference Citation Analysis]
6 Lin Q, Jiang Y, Zhou F, Zhang Y. Fatty acid synthase (FASN) inhibits the cervical squamous cell carcinoma (CESC) progression through the Akt/mTOR signaling pathway. Gene 2022. [DOI: 10.1016/j.gene.2022.147023] [Reference Citation Analysis]
7 Lung J, Hung M, Wang T, Chen K, Luo C, Jiang Y, Wu S, Lee L, Lin P, Chen F, Liao H, Lin Y. Lipid Droplets in Lung Cancers Are Crucial for the Cell Growth and Starvation Survival. IJMS 2022;23:12533. [DOI: 10.3390/ijms232012533] [Reference Citation Analysis]
8 Sweed E, Sweed D, Galal N, Abd-elhafiz HI. Dapagliflozin Protection against Myocardial Ischemia by Modulating Sodium-glucose Transporter 2 Inhibitor, Silent Information Regulator 1, and Fatty Acid Synthase Expressions. Open Access Maced J Med Sci 2022;10:1544-1554. [DOI: 10.3889/oamjms.2022.10861] [Reference Citation Analysis]
9 Han J, Wang Y, Zhou H, Ai S, Wan D, Sun J. Integrated Bioinformatics and Experimental Analysis Identified TRIM28 a Potential Prognostic Biomarker and Correlated with Immune Infiltrates in Liver Hepatocellular Carcinoma. Computational and Mathematical Methods in Medicine 2022;2022:1-17. [DOI: 10.1155/2022/6267851] [Reference Citation Analysis]
10 Efeoglu E, Henry M, Clynes M, Meleady P. Label-Free Quantitative Proteomics Analysis of Adriamycin Selected Multidrug Resistant Human Lung Cancer Cells. Biomolecules 2022;12:1401. [PMID: 36291610 DOI: 10.3390/biom12101401] [Reference Citation Analysis]
11 Chi C, Harth L, Galera MR, Torrealba MP, Vadivel CK, Geisler C, Bonefeld CM, Nielsen PR, Bzorek M, Becker JC, Gjerdrum LMR, Ødum N, Woetmann A. Concomitant Inhibition of FASN and SREBP Provides a Promising Therapy for CTCL. Cancers (Basel) 2022;14:4491. [PMID: 36139650 DOI: 10.3390/cancers14184491] [Reference Citation Analysis]
12 Zhang Y, Kong X, Xin S, Bi L, Sun X, Jia S. Discovery of Lipid Metabolism-Related Genes for Predicting Tumor Immune Microenvironment Status and Prognosis in Prostate Cancer. Journal of Oncology 2022;2022:1-14. [DOI: 10.1155/2022/8227806] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Zhang L, Chang N, Liu J, Liu Z, Wu Y, Sui L, Chen W. Reprogramming lipid metabolism as potential strategy for hematological malignancy therapy. Front Oncol 2022;12:987499. [DOI: 10.3389/fonc.2022.987499] [Reference Citation Analysis]
14 Aria H, Rezaei M, Nazem S, Daraei A, Nikfar G, Mansoori B, Bahmanyar M, Tavassoli A, Vakil MK, Mansoori Y. Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance. Front Immunol 2022;13:947885. [DOI: 10.3389/fimmu.2022.947885] [Reference Citation Analysis]
15 Deng S, Chen B, Huo J, Liu X. Therapeutic potential of NR4A1 in cancer: Focus on metabolism. Front Oncol 2022;12:972984. [DOI: 10.3389/fonc.2022.972984] [Reference Citation Analysis]
16 Ballinger TJ, Djuric Z, Sardesai S, Hovey KM, Andrews CA, Brasky TM, Zhang JT, Rohan TE, Saquib N, Shadyab AH, Simon M, Wactawski-wende J, Wallace R, Kato I. Proton Pump Inhibitor Use and Obesity-Associated Cancer in the Women’s Health Initiative. Nutrition and Cancer. [DOI: 10.1080/01635581.2022.2108467] [Reference Citation Analysis]
17 Mátyási B, Petővári G, Dankó T, Butz H, Likó I, Lőw P, Petit I, Bittar R, Bonnefont-Rousselot D, Farkas Z, Szeniczey T, Molnár K, Pálóczi K, Buzás EI, Boissan M, Sebestyén A, Takács-Vellai K. Extracellular Vesicle-Mediated Metastasis Suppressors NME1 and NME2 Modify Lipid Metabolism in Fibroblasts. Cancers (Basel) 2022;14:3913. [PMID: 36010906 DOI: 10.3390/cancers14163913] [Reference Citation Analysis]
18 Vasseur S, Guillaumond F. Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance. Oncogenesis 2022;11:46. [PMID: 35945203 DOI: 10.1038/s41389-022-00420-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Rishmawi S, Haddad F, Dokmak G, Karaman R. A Comprehensive Review on the Anti-Cancer Effects of Oleuropein. Life (Basel) 2022;12:1140. [PMID: 36013319 DOI: 10.3390/life12081140] [Reference Citation Analysis]
20 Chen P, Li S, Zhou Z, Wang X, Shi D, Li Z, Li X, Xiao Y. Liver fat metabolism of broilers regulated by Bacillus amyloliquefaciens TL via stimulating IGF-1 secretion and regulating the IGF signaling pathway. Front Microbiol 2022;13:958112. [DOI: 10.3389/fmicb.2022.958112] [Reference Citation Analysis]
21 Zhao Q, Lin X, Wang G. Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer. Front Oncol 2022;12:952371. [DOI: 10.3389/fonc.2022.952371] [Reference Citation Analysis]
22 Wang L, Ruan Y, Wu X, Zhou X, Wang F. lncRNA ZFAS1 Promotes HMGCR mRNA Stabilization via Binding U2AF2 to Modulate Pancreatic Carcinoma Lipometabolism. Journal of Immunology Research 2022;2022:1-12. [DOI: 10.1155/2022/4163198] [Reference Citation Analysis]
23 Mo W, Xu W, Hong M, Yang T, Shi Y, Jiao Y, Nie J, Cui F, Cao J, Zhang S. Proteomic and miRNA profiling of radon-induced skin damage in mice: FASN regulated by miRNAs. Journal of Radiation Research 2022. [DOI: 10.1093/jrr/rrac037] [Reference Citation Analysis]
24 Du P, Chai Y, Zong S, Yue J, Xiao H. Identification of a Prognostic Model Based on Fatty Acid Metabolism-Related Genes of Head and Neck Squamous Cell Carcinoma. Front Genet 2022;13:888764. [DOI: 10.3389/fgene.2022.888764] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Wang N, Gu Y, Li L, Chi J, Liu X, Xiong Y, Zhong C. Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer. J Inflamm Res 2022;15:3477-99. [PMID: 35726216 DOI: 10.2147/JIR.S357144] [Reference Citation Analysis]
26 Navarro C, Ortega Á, Santeliz R, Garrido B, Chacín M, Galban N, Vera I, De Sanctis JB, Bermúdez V. Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches. Pharmaceutics 2022;14:1303. [PMID: 35745875 DOI: 10.3390/pharmaceutics14061303] [Reference Citation Analysis]
27 Feng S, Lou K, Zou X, Zou J, Zhang G. The Potential Role of Exosomal Proteins in Prostate Cancer. Front Oncol 2022;12:873296. [DOI: 10.3389/fonc.2022.873296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Arunasalam M, Chong V, Mareshvaran SR, Yee VNF, Gaurav A, Salvamani S, Lim CSY, Gunasekaran B. Identification of natural product inhibitors of de novo lipogenesis enzymes as an anti-cancer strategy: An in silico approach. APJMBB 2022. [DOI: 10.35118/apjmbb.2022.030.2.01] [Reference Citation Analysis]
29 Fan H, Huang W, Guo Y, Ma X, Yang J. α-Linolenic Acid Suppresses Proliferation and Invasion in Osteosarcoma Cells via Inhibiting Fatty Acid Synthase. Molecules 2022;27:2741. [DOI: 10.3390/molecules27092741] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Sun X, Zhang Y, Chen Y, Xin S, Jin L, Liu X, Zhou Z, Zhang J, Mei W, Zhang B, Yao X, Yang G, Ye L, Cai D. In Silico Establishment and Validation of Novel Lipid Metabolism-Related Gene Signature in Bladder Cancer. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/3170950] [Reference Citation Analysis]
31 Tsuruda T, Sato Y, Tomita M, Tanaka H, Hatakeyama K, Otsu M, Kawano A, Nagatomo K, Yoshikawa N, Ikeda R, Asada Y, Kaikita K. Aberrant Expression of Cardiac Troponin-T in Lung Cancer Tissues in Association With Pathological Severity. Front Cardiovasc Med 2022;9:833649. [DOI: 10.3389/fcvm.2022.833649] [Reference Citation Analysis]
32 Pan S, Chen R. Pathological implication of protein post-translational modifications in cancer. Molecular Aspects of Medicine 2022. [DOI: 10.1016/j.mam.2022.101097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Najem A, Soumoy L, Sabbah M, Krayem M, Awada A, Journe F, Ghanem GE. Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma. Cells 2022;11:1157. [PMID: 35406721 DOI: 10.3390/cells11071157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Herrero-aguayo V, Sáez-martínez P, Jiménez-vacas JM, Moreno-montilla MT, Montero-hidalgo AJ, Pérez-gómez JM, López-canovas JL, Porcel-pastrana F, Carrasco-valiente J, Anglada FJ, Gómez-gómez E, Yubero-serrano EM, Ibañez-costa A, Herrera-martínez AD, Sarmento-cabral A, Gahete MD, Luque RM. Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool. Molecular Therapy - Nucleic Acids 2022;27:1164-1178. [DOI: 10.1016/j.omtn.2022.02.010] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
35 Liu M, Li H, Wang X, Xia R, Li X, Ma Y, Wang M, Zhang H. TIGAR drives colorectal cancer ferroptosis resistance through ROS/AMPK/SCD1 pathway. Free Radical Biology and Medicine 2022. [DOI: 10.1016/j.freeradbiomed.2022.03.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Krauß D, Fari O, Sibilia M. Lipid Metabolism Interplay in CRC—An Update. Metabolites 2022;12:213. [DOI: 10.3390/metabo12030213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
37 Kelly JM, Jeitner TM, Waterhouse NN, Qu W, Linstad EJ, Samani B, Williams C, Nikolopoulou A, Amor-coarasa A, Dimagno SG, Babich JW. Synthesis and Evaluation of 11C-Labeled Triazolones as Probes for Imaging Fatty Acid Synthase Expression by Positron Emission Tomography. Molecules 2022;27:1552. [DOI: 10.3390/molecules27051552] [Reference Citation Analysis]
38 Cui MY, Yi X, Zhu DX, Wu J. Aberrant lipid metabolism reprogramming and immune microenvironment for gastric cancer: a literature review. Transl Cancer Res 2021;10:3829-42. [PMID: 35116681 DOI: 10.21037/tcr-21-655] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
39 Gyamfi J, Kim J, Choi J. Cancer as a Metabolic Disorder. Int J Mol Sci 2022;23:1155. [PMID: 35163079 DOI: 10.3390/ijms23031155] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
40 Batchuluun B, Pinkosky SL, Steinberg GR. Lipogenesis inhibitors: therapeutic opportunities and challenges. Nat Rev Drug Discov 2022. [PMID: 35031766 DOI: 10.1038/s41573-021-00367-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
41 李 林. Research Advancements in Hepatocellular Carcinoma and Ferroptosis. ACM 2022;12:9363-9368. [DOI: 10.12677/acm.2022.12101354] [Reference Citation Analysis]
42 Read GH, Bailleul J, Vlashi E, Kesarwala AH. Metabolic response to radiation therapy in cancer. Mol Carcinog 2021. [PMID: 34961986 DOI: 10.1002/mc.23379] [Reference Citation Analysis]
43 Hernández-Quiles M, Baak R, Borgman A, den Haan S, Sobrevals Alcaraz P, van Es R, Kiss-Toth E, Vos H, Kalkhoven E. Comprehensive Profiling of Mammalian Tribbles Interactomes Implicates TRIB3 in Gene Repression. Cancers (Basel) 2021;13:6318. [PMID: 34944947 DOI: 10.3390/cancers13246318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Yang JS, Yoon N, Kong M, Jung BH, Lee H, Park J. USP14 Regulates Cancer Cell Growth in a Fatty Acid Synthase-Independent Manner. Int J Mol Sci 2021;22:13437. [PMID: 34948233 DOI: 10.3390/ijms222413437] [Reference Citation Analysis]
45 Liao Y, Li D, Zhou X, Peng Z, Meng Z, Liu R, Yang W. Pyruvate Might Bridge Gut Microbiota and Muscle Health in Aging Mice After Chronic High Dose of Leucine Supplementation. Front Med (Lausanne) 2021;8:755803. [PMID: 34881260 DOI: 10.3389/fmed.2021.755803] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
46 Martin-perez M, Urdiroz-urricelqui U, Bigas C, Benitah SA. Lipid metabolism in metastasis and therapy. Current Opinion in Systems Biology 2021;28:100401. [DOI: 10.1016/j.coisb.2021.100401] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
47 Wu S, Huang C, Chen Y, Huang H, Huang W, Lai Y. Momordica charantia leaf extract reduces hepatic lipid accumulation and diet-induced dyslipidemia in zebrafish through lipogenesis and beta-oxidation. Journal of Functional Foods 2021;87:104857. [DOI: 10.1016/j.jff.2021.104857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Singh G, Storey KB. MicroRNA Cues from Nature: A Roadmap to Decipher and Combat Challenges in Human Health and Disease? Cells 2021;10:3374. [PMID: 34943882 DOI: 10.3390/cells10123374] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
49 Yang Y, He J, Zhang B, Zhang Z, Jia G, Liu S, Wu T, He X, Wang N. SLC25A1 promotes tumor growth and survival by reprogramming energy metabolism in colorectal cancer. Cell Death Dis 2021;12:1108. [PMID: 34839347 DOI: 10.1038/s41419-021-04411-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
50 Eroglu EC, Tunug S, Geckil OF, Gulec UK, Vardar MA, Paydas S. Discovery of metabolomic biomarkers for discriminating platinum-sensitive and platinum-resistant ovarian cancer by using GC-MS. Eur J Mass Spectrom (Chichester) 2021;:14690667211057996. [PMID: 34806450 DOI: 10.1177/14690667211057996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Chen Y, Lee K, Liang Y, Qin S, Zhu Y, Liu J, Yao S. A Cholesterol Homeostasis-Related Gene Signature Predicts Prognosis of Endometrial Cancer and Correlates With Immune Infiltration. Front Genet 2021;12:763537. [PMID: 34790227 DOI: 10.3389/fgene.2021.763537] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
52 Castelli S, De Falco P, Ciccarone F, Desideri E, Ciriolo MR. Lipid Catabolism and ROS in Cancer: A Bidirectional Liaison. Cancers (Basel) 2021;13:5484. [PMID: 34771647 DOI: 10.3390/cancers13215484] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
53 Goodrich JM, Calkins MM, Caban-Martinez AJ, Stueckle T, Grant C, Calafat AM, Nematollahi A, Jung AM, Graber JM, Jenkins T, Slitt AL, Dewald A, Cook Botelho J, Beitel S, Littau S, Gulotta J, Wallentine D, Hughes J, Popp C, Burgess JL. Per- and polyfluoroalkyl substances, epigenetic age and DNA methylation: a cross-sectional study of firefighters. Epigenomics 2021;13:1619-36. [PMID: 34670402 DOI: 10.2217/epi-2021-0225] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
54 Franz A, Coscia F, Shen C, Charaoui L, Mann M, Sander C. Molecular response to PARP1 inhibition in ovarian cancer cells as determined by mass spectrometry based proteomics. J Ovarian Res 2021;14:140. [PMID: 34686201 DOI: 10.1186/s13048-021-00886-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Schroeder B, Vander Steen T, Espinoza I, Venkatapoorna CMK, Hu Z, Silva FM, Regan K, Cuyàs E, Meng XW, Verdura S, Arbusà A, Schneider PA, Flatten KS, Kemble G, Montero J, Kaufmann SH, Menendez JA, Lupu R. Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells. Cell Death Dis 2021;12:977. [PMID: 34675185 DOI: 10.1038/s41419-021-04262-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
56 Ossoli A, Wolska A, Remaley AT, Gomaraschi M. High-density lipoproteins: A promising tool against cancer. Biochim Biophys Acta Mol Cell Biol Lipids 2022;1867:159068. [PMID: 34653581 DOI: 10.1016/j.bbalip.2021.159068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
57 Okagu IU, Ndefo JC, Aham EC, Udenigwe CC. Zanthoxylum Species: A Review of Traditional Uses, Phytochemistry and Pharmacology in Relation to Cancer, Infectious Diseases and Sickle Cell Anemia. Front Pharmacol 2021;12:713090. [PMID: 34603027 DOI: 10.3389/fphar.2021.713090] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
58 Lyu Q, Zhu W, Wei T, Ding W, Cao M, Wang Q, Guo L, Luo P, Zhang J. High mutations in fatty acid metabolism contribute to a better prognosis of small-cell lung cancer patients treated with chemotherapy. Cancer Med 2021;10:7863-76. [PMID: 34564955 DOI: 10.1002/cam4.4290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Hu Y, Zai H, Jiang W, Ou Z, Yao Y, Zhu Q. The Mutual Inhibition of FoxO1 and SREBP-1c Regulated the Progression of Hepatoblastoma by Regulating Fatty Acid Metabolism. Mediators Inflamm 2021;2021:5754592. [PMID: 34539243 DOI: 10.1155/2021/5754592] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Pulla LSS, Begum Ahil S. Review on target domains and natural compound-based inhibitors of fatty acid synthase for anticancer drug discovery. Chem Biol Drug Des 2021;98:869-84. [PMID: 34459114 DOI: 10.1111/cbdd.13942] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Selvarajah B, Azuelos I, Anastasiou D, Chambers RC. Fibrometabolism-An emerging therapeutic frontier in pulmonary fibrosis. Sci Signal 2021;14:eaay1027. [PMID: 34429381 DOI: 10.1126/scisignal.aay1027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
62 Huang SF, Peng XF, Jiang L, Hu CY, Ye WC. LncRNAs as Therapeutic Targets and Potential Biomarkers for Lipid-Related Diseases. Front Pharmacol 2021;12:729745. [PMID: 34421622 DOI: 10.3389/fphar.2021.729745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Sun J, Wang Z, Chen L, Sun G. Hypolipidemic Effects and Preliminary Mechanism of Chrysanthemum Flavonoids, Its Main Components Luteolin and Luteoloside in Hyperlipidemia Rats. Antioxidants (Basel) 2021;10:1309. [PMID: 34439559 DOI: 10.3390/antiox10081309] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
64 Wong XK, Yeong KY. A Patent Review on the Current Developments of Benzoxazoles in Drug Discovery. ChemMedChem 2021. [PMID: 34289258 DOI: 10.1002/cmdc.202100370] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
65 Rabelo ILA, Arnaud-Sampaio VF, Adinolfi E, Ulrich H, Lameu C. Cancer Metabostemness and Metabolic Reprogramming via P2X7 Receptor. Cells 2021;10:1782. [PMID: 34359950 DOI: 10.3390/cells10071782] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
66 Sun D, Zhao T, Long K, Wu M, Zhang Z. Triclosan down-regulates fatty acid synthase through microRNAs in HepG2 cells. Eur J Pharmacol 2021;907:174261. [PMID: 34144025 DOI: 10.1016/j.ejphar.2021.174261] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
67 Nenkov M, Ma Y, Gaßler N, Chen Y. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy. Int J Mol Sci 2021;22:6262. [PMID: 34200820 DOI: 10.3390/ijms22126262] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
68 Selma-Gracia R, Megušar P, Haros CM, Laparra Llopis JM. Immunonutritional Bioactives from Chenopodium quinoa and Salvia hispanica L. Flour Positively Modulate Insulin Resistance and Preserve Alterations in Peripheral Myeloid Population. Nutrients 2021;13:1537. [PMID: 34063252 DOI: 10.3390/nu13051537] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
69 Demény MA, Virág L. The PARP Enzyme Family and the Hallmarks of Cancer Part 1. Cell Intrinsic Hallmarks. Cancers (Basel) 2021;13:2042. [PMID: 33922595 DOI: 10.3390/cancers13092042] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
70 Hager-Theodorides AL, Massouras T, Simitzis PE, Moschou K, Zoidis E, Sfakianaki E, Politi K, Charismiadou M, Goliomytis M, Deligeorgis S. Hesperidin and Naringin Improve Broiler Meat Fatty Acid Profile and Modulate the Expression of Genes Involved in Fatty Acid β-oxidation and Antioxidant Defense in a Dose Dependent Manner. Foods 2021;10:739. [PMID: 33807218 DOI: 10.3390/foods10040739] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
71 Franz A, Coscia F, Shen C, Charaoui L, Mann M, Sander C. Molecular Response to PARP1 Inhibition in Ovarian Cancer Cells as Determined by Mass Spectrometry Based Proteomics.. [DOI: 10.1101/2021.03.12.435005] [Reference Citation Analysis]
72 Matsushita Y, Nakagawa H, Koike K. Lipid Metabolism in Oncology: Why It Matters, How to Research, and How to Treat. Cancers (Basel) 2021;13:474. [PMID: 33530546 DOI: 10.3390/cancers13030474] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 29.0] [Reference Citation Analysis]
73 毕 鹏. Classification Technology and Application of Multifunctional Enzymes. CSA 2021;11:476-488. [DOI: 10.12677/csa.2021.113048] [Reference Citation Analysis]